Total planned funding: $30,995,124
Allocations
Countries/Regions
| Central Asia Region | $30,995,124 |
Organizational Types
| Own Agency | $30,995,124 |
Program Areas
| Management and Operations | $22,194,267 |
| Prevention | $3,346,293 |
| Governance and Systems | $2,662,278 |
| Care | $1,116,459 |
| Testing | $944,824 |
| Treatment | $731,003 |
Budget Codes
| HVMS: Management and Operations | $22,194,267 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,395,952 |
| HLAB: Laboratory Infrastructure | $1,098,596 |
| HVSI: Strategic Information | $1,014,718 |
| HBHC: Care: Adult Care and Support | $954,352 |
| HVCT: Testing: HIV Testing and Counseling | $944,824 |
| HTXS: Treatment: Adult Treatment | $712,834 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $580,901 |
| OHSS: Health Systems Strengthening | $548,964 |
| HMBL: Biomedical Prevention: Blood Safety | $228,932 |
| HVTB: Care: TB/HIV | $162,107 |
| HMIN: Biomedical Prevention: Injection Safety | $140,508 |
| HTXD: Treatment: ARV Drugs | $18,169 |
Top Partner Programs
USG Aggregated Agencies:
$19,855,761
Countries/Regions
U.S. Centers for Disease Control and Prevention:
$6,221,704
Countries/Regions
Central Asia Region
| 2013 | $3,238,500 |
| 2014 | $2,983,204 |
U.S. Agency for International Development:
$4,917,659
Countries/Regions
Central Asia Region
| 2013 | $2,538,500 |
| 2014 | $2,379,159 |